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PERSPECTIVE

Assessment of risk of insect-resistant transgenic
crops to nontarget arthropods
Jörg Romeis1, Detlef Bartsch2, Franz Bigler1, Marco P Candolfi3,19, Marco M C Gielkens4, Susan E Hartley5,
Richard L Hellmich6, Joseph E Huesing7, Paul C Jepson8, Raymond Layton9, Hector Quemada10,
Alan Raybould11, Robyn I Rose12, Joachim Schiemann13, Mark K Sears14, Anthony M Shelton15,
Jeremy Sweet16, Zigfridas Vaituzis17 & Jeffrey D Wolt18
An international initiative is developing a scientifically rigorous
approach to evaluate the potential risks to nontarget arthropods
(NTAs) posed by insect-resistant, genetically modified (IRGM)
crops. It adapts the tiered approach to risk assessment
that is used internationally within regulatory toxicology and
environmental sciences. The approach focuses on the formulation
and testing of clearly stated risk hypotheses, making maximum
use of available data and using formal decision guidelines
to progress between testing stages (or tiers). It is intended
to provide guidance to regulatory agencies that are currently
developing their own NTA risk assessment guidelines for IRGM
crops and to help harmonize regulatory requirements between
different countries and different regions of the world.
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IRGM crops that express Cry proteins derived from the soil bacterium
Bacillus thuringiensis (Bt) have been grown in several countries on a
steadily increasing acreage since their introduction in 1996. In 2006,
transgenic varieties of cotton and maize that express Bt proteins were
grown on 32.1 million hectares worldwide1. Several crops expressing
novel insecticidal proteins are also under development and these are
expected to be commercialized in the near future. (Although insecticidal traits associated with commercialized genetically modified (GM)
crops have all been proteins, we recognize that future traits might not
necessarily be restricted to this class of molecule.) In common with
conventional agricultural pest control products (which include synthetic and organic insecticides, biological control agents and host-plant
resistance developed by conventional breeding), one of the risks associated with the growing of IRGM crops is their potential to adversely
affect nontarget organisms. These include a range of arthropod species
that fulfill important ecological functions such as biological control,
pollination and decomposition. The potential for adverse effects of
IRGM crops on these NTAs has been evaluated as part of the environmental risk assessment (ERA) process that takes place before the
decision to cultivate these crops commercially2,3. The relative novelty of
IRGM crops and the complexity and sophistication of ERA procedures
present regulatory authorities with a challenge when they are required
to develop appropriate risk assessment methodologies. This is a particularly difficult task in the developing world, where the regulatory
infrastructure is still being established.
General guidance for conducting an ERA for genetically modified
(GM) plants exists4–9. There remains, however, a need for detailed
descriptions for NTA risk assessment procedures, including selection
criteria for the NTA test species and test methods that can apply to different regions if these general guidelines are to be adapted for specific
crops in specific agriculture ecosystems. To address this need and to
formulate the underlying rationale of the existing ERA approaches,
an initiative was launched within the GM organisms working group
of the West Palaearctic Regional Section (WPRS) of the International
Organization for Biological and Integrated Control of Noxious Animals
and Plants (IOBC) (http://www.iobc-wprs.org/)10. The group consists
of European and North American scientists from public research institutes, regulatory agencies, the agricultural biotechnology industry and
a commercial testing laboratory. The current focus of this group is the
development of an IRGM-specific rationale for a tiered toxicological
testing system which, when integrated with exposure, will enable poten-
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The data commonly requested by authorities
to satisfy regulatory assessments are particularly
important for the establishment of familiarity
and typically include a description of the host
crop, the source and molecular characterization
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ment.2,8,15,16,18. A ‘meaningful difference’, in this
context, refers to a substance or another attribute
Figure 1 Assessment continuum within a tiered scheme of ecological risk assessment. The decision
previously associated with effects that may be
to reject the risk hypothesis includes consideration of residual uncertainties. With increasing tiers,
of environmental concern (e.g., an unintended
the assessment becomes more complex and realistic, with conclusions that are more specific. The
increase in alkaloid levels in GM cotton plants
assessment can stop at any stage during the process as soon as sufficient information has been
modified to express a Cry protein could affect
compiled to address the risk hypothesis. Thus collection of data irrelevant to the risk assessment is
minimized. N, level of risk assessment tier; NTA, nontarget arthropod.
NTAs). It is evident that the degree of familiarity
with a given crop and IRGM approach and its
tial risks to NTAs to be defined and assessed. This is intended to provide conventional comparators will increase over time and with experience.
The problem formulation may result in recommendations that a narregulators with a scientific rationale for the risk assessment decisions that
they make. Ultimately, the risk management decision that regulators make rowly defined set of experimental evaluations should be undertaken for
the risk assessment of some IRGM crops with well-known characteristics.
also takes into account relevant social and political considerations11,12.
In the following article, we outline the basic principles and rationale of This could result in criticism that the risk assessment is superficial and not
the tiered approach. We also describe the ways in which this approach has likely to detect potential risks. However, the process explicitly considers the
been refined by scientists from public, industrial and regulatory sectors, specifics of the stressor’s mode of action, spectrum of activity and levels of
exposure of NTAs to the stressor. Data to support the problem formulawho have extensive experience with IRGM crops.
tion may derive, for example, from the tests carried out during IRGM plant
Problem formulation
development. The pest activity spectrum is commonly explored during
In our approach, the problem formulation stage is designed to identify development by testing the activity of the insecticidal protein against a
the areas of greatest concern or uncertainty concerning ecological risks, range of pest species belonging to different orders. Additional data may
and to define the scope of the risk assessment by generating testable sci- also exist in the literature concerning the spectrum of activity of some proentific hypotheses that are subsequently addressed in the analytical phase teins (e.g., certain Cry proteins from Bt) that have been studied by public
of the risk assessment8,13,14. The information that is considered during sector scientists21,22. The information base that is inherent to the concept
problem formulation takes many forms, including published scientific of familiarity is therefore considerable; thus, we argue that risk assessment
literature, expert opinion, stakeholder deliberations and data developed for specific applications associated with familiar crops/traits can be both
by the registrants and submitted to the regulatory authority as part of the thorough and accurate without requiring extensive additional testing.
registration dossier. This information establishes the level of ‘familiarity’
Problem formulation identifies scientifically analyzable endpoints that
(that is, the similarities in ecologically relevant characteristics) between the reflect management or protection goals that are set by public policy. For
IRGM crop and nontransformed crop15–17 and, together with the related example, if ‘protection of biodiversity’ is the management goal, a typical
concept for food of ‘substantial equivalence’, serves as a starting point to assessment endpoint would be the abundance and species richness of
focus the ERA process on potential stressors of concern18,19. If substantial certain groups of NTAs, such as those that fulfill important ecological
equivalence and familiarity are established, the ERA can proceed with functions. Different regulatory agencies may define different assessment
emphasis on narrowly defined, stressor-mediated effects that arise from endpoints or even have different management objectives. These must all
the expressed trait in the IRGM crop (e.g., a Bt protein)14,20. In cases where be considered explicitly in the problem formulation stage so that the risk
substantial differences other than those directly related to the expressed hypotheses can generate data that address the goals of the regulator and
trait are detected, these characteristics become additional potential stress- the requirements of the policy. The problem formulation should culmiors that also need to be evaluated, following the same tiered approach that nate in a conceptual model and analysis plan that is consistent with the
we outline. Thus, the greater the extent of familiarity between the IRGM risk hypotheses and that establishes the relationship between the stressor
crop and the nontransformed crop, the more specific and focused the and the ecological impacts of concern (the assessment endpoints). The
risk hypotheses will be. The feedback inherent in the process described conceptual model should take into account ecological considerations that
increases the efficiency of ERA for familiar crops and focuses resources might affect the nature and extent of possible environmental impacts,
on less familiar commodities as they arise.
including the intended scale of cultivation of the IRGM crop.
Risk conclusion

© 2008 Nature Publishing Group http://www.nature.com/naturebiotechnology
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The ERA framework and moving through it
Scientific assessment of risks from IRGM plants is conceptually similar
to the assessment of risks from traditional synthetic insecticides even
though insecticidal proteins expressed by GM plants may differ from
synthetic insecticides (e.g., by mode of action, specificity, exposure
route)23. The tiered process of toxicity testing is generally used to assess
the nontarget effects posed by traditional insecticides24 because it is
suitable for assisting the decision-making process in an effective and
rigorous way. We argue that it is also the most rigorous approach, from
both scientific and regulatory standpoints, for determining the potential
of IRGM plants to adversely affect NTAs. Versions of this approach are
also in current use in established regulatory systems for GM crops4,8.
A typical risk hypothesis that emerges from problem formulation
may be that the stressor (that is, the insecticidal protein) does not harm
NTAs at the concentration expressed in the field. The testing of this
hypothesis frequently leads to toxicity tests on select arthropod species.
These tests are conducted within experimental ‘tiers’ that are initiated
with elevated dose exposure tests (e.g., at ten times the expected environmental exposure), often using laboratory procedures with purified
protein in artificial diets and proceeding to more realistic scenarios of
exposure with IRGM plants if impacts exceed certain specified threshold values (Fig. 1).
Examples of the risk hypotheses that are addressed at the different
tiers are provided in Figure 1. The conceptual pathway leads from relatively simple and controllable lower tier assessments to increasingly
complex higher tier assessments. The conclusion regarding risk drawn
at each tier will lead either to a regulatory decision after the residual
uncertainty of the assessment has been defined or to additional investigations. These need to be conducted at the appropriate tier, which could

be any of the lower, current or higher tiers of evaluation. Throughout
the assessment, the risk assessor needs to confirm continually that the
problem being addressed is still appropriate and, if necessary, revisit the
problem formulation.
Lower tier tests serve to identify potential hazards, if they exist, and are
typically conducted in controlled laboratory conditions (Supplementary
Note online). Lower-tier tests are designed to measure a specific endpoint (or set of endpoints) under controlled conditions using protein
concentrations that are usually several times higher than those present
in the field. Such studies provide a powerful means to detect hazards
because the biological impacts of the insecticidal protein can be isolated25. The tests are not meant to reflect real-world exposures but to
increase the likelihood that a hazard will be detected should one be
present, and so provide confidence of minimal risk should no adverse
effect be detected. The sequence of testing continues after the initial
elevated-dose or dose-response tests if potential hazards were detected
(that is, the ‘no-effect’ hypothesis had to be rejected) or if unacceptable
uncertainties about possible hazards remain (Fig. 1). For example, conducting further lower tier tests in the laboratory can refine the hazard
assessment by increasing the taxonomic breadth or local relevance of
test species. In cases where lower tier tests detect a potential hazard (that
is, the ‘no-effect’ hypothesis is rejected), higher tier tests, which include
more complex semi-field (that is, under containment using live GM
plant material) or open field tests, can then serve to confirm whether
an effect can still be detected under more realistic rates and routes of
exposure to the protein (Fig. 1). In cases where uncertainty about the
risk remains after higher tier studies, one can always return to lower
tiers to conduct additional studies, for example, by including additional
test species (Fig. 1). In exceptional cases, higher-tier studies or studies

Box 1 Evaluation path for Bt maize expressing Cry1Ab for nontarget arthropods
In the evaluation of Bt maize expressing Cry1Ab, entities of concern included biological control organisms belonging to, for example, the
orders of Coleoptera (lady beetles), Neuroptera (lacewings) and Hymenoptera (parasitoid wasps), as well as pollinators such as bees (also
Hymenoptera), decomposers such as soil arthropods (for example, springtails) and nontarget Lepidoptera. The problem formulation identified
several risk hypotheses that were subsequently addressed in the analytical phase of the risk assessment (Fig. 2). Because analysis of the
available precursor information revealed with sufficient certainty that the only meaningful difference between Bt maize and its nontransformed
comparators was the expression of the
Cry1Ab protein, early tier (worst-case) studies
were conducted using elevated doses of
Lab
Long-term lab Field
Lab
protein tissue
semi-field
(open)
Problem
Risk
purified protein or plant tissue. These studies
(enclosed)
formulation
hypotheses
confirmed existing knowledge (precursor
information) that these proteins are not
Precursor information
1
likely to affect nonlepidopteran insects (risk
Lady beetles
Familiarity/equivalence
Lacewings
Biocontrol
22,42
• Agronomic traits
hypotheses 1–3)
. Testing could thus be
Parasitoid wasps
organisms
• Composition data
terminated at this early tier. The potential
• History of use
hazard to nontarget Lepidoptera (risk
2
Stressor characterization
hypothesis 4) was recognized initially but it
Honey bees
Pollinators
• Mode of action
43
was concluded that the risk is negligible .
• Spectrum of activity
• Molecular characterization
Additional studies under more realistic
3
• Expression profile
exposure conditions were triggered once a
Decomposers Springtails
note44 and a more comprehensive study45
4
had revealed a hazard of Cry1Ab to larvae
Nontarget
Monarch butterflies
of the monarch butterfly. Studies were
Lepidoptera
conducted under semi-field conditions. These
.
studies concluded that the risk of Cry1Ab
.
Worst case
Exposure
Realistic
.
continuum
maize to monarch populations is negligible
because larval exposure to Cry1Ab toxin
under field conditions is low46–49 confirming
the initial risk assessment43.

Figure 2 Reconstruction of NTA risk assessment for Bt maize expressing Cry1Ab showing that
different risk hypotheses require different types of data and synthesis at different tiers.
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Species selection
For practical reasons, only a small fraction of potentially exposed terrestrial arthropods can be considered for regulatory testing. It is therefore necessary to select appropriate species to serve as surrogates that
can be tested effectively under laboratory conditions27–29. For regulatory testing of IRGM plants, surrogate species should be representatives of ecologically and economically important NTA taxa in the crop
and represent different ecological functions including predation and
parasitism of pest organisms, pollination and decomposition of plant
material27,30. Key species or guilds that are representative of different
functional groups are known in most systems and appropriate surrogates can therefore be selected. Despite recognized limitations31, the
application of the surrogate concept is widely applied in related fields
including regulatory toxicity testing28,29,32,33 and environmental monitoring34–36. In addition, the risk assessment may consider species with
special aesthetic or cultural value or species classified as threatened or
endangered. These species are regionally specific and can be evaluated
within the ERA independent of their ecological function.
The most effective surrogate taxa, for example honeybees (Apis mellifera), are representatives of NTA taxa that are found in many different
crops or regions. More specific, crop-associated species may be selected
that represent an important genus (e.g., Orius spp.), and other taxa
may be selected that are broadly representative of whole families (e.g.,
parasitic wasps of the Ichneumonidae) or orders (e.g., Coleoptera) that
are known to be important. Even the nontarget pest species that are
screened for their sensitivity to the insecticidal protein during product
development can serve as surrogates for NTAs.
Information on the stressor (e.g., protein specificity, and the pattern
and level of expression in the plant), together with information on the
feeding habits of the test species, which is accumulated during problem formulation, must be
Box 2 Nontarget species selection
considered during the selection of appropriate surrogates (Box 2). In general, nontarget
The number and type of NTA species that need to be tested depend on the risk hypotheses
species that are related taxonomically to the
generated during the problem formulation. The species selection will also depend on
target pests are most likely to be affected by the
how much information already exists to test the hypotheses: the level and quality of
protein; thus selection of these taxa increases
information on the plant, the specific stressor (that is, the insecticidal protein) expressed
the likelihood of detecting a hazard if one
(e.g., spectrum of activity, mode of action, expression level) together with information
exists. Species that are not exposed to the
about the feeding habits of the NTAs. Increasing the level and quality of information
insecticidal protein do not need to be tested
reduces the number of risk hypotheses that will require testing.
to draw a negligible-risk conclusion. Some
additional, practical considerations include
Example 1: novel Bt maize event expressing Cry1Ab. There is a high probability, based
the ease of working with a species, the potenupon an extensive research history, that the protein would be active only against
tial for unambiguous taxonomic recognition,
Lepidoptera and that harm to NTAs in other taxonomic orders would be negligible.
the ability to rear the species in captivity, the
Additionally, there is a high level of familiarity with maize, the trait and the toxin from
availability of permanent source colonies and
experience with other Cry1Ab-expressing maize events. (Event indicates a unique
validated and accepted test methods.
transformation of a plant by insertion of a particular transgene into its genome). Further
The purpose of using IRGM plants is the
testing for this novel event is not scientifically justified provided that problem formulation
same
as for any other pest management tactic;
shows the expression of the Cry1Ab protein is the only relevant difference compared with
that
is,
to reduce pest populations below ecoclosely related, nontransformed maize varieties and that expression levels are similar to
nomic injury levels. As a result of applying the
those in previously evaluated events.
tactic, the abundance of pest insects should be
significantly reduced and this will have correExample 2: novel Bt maize event expressing a Cry3 protein. Because the protein is
sponding implications for those organisms that
targeting corn rootworms (Diabrotica spp.) and has a known specificity to Coleoptera,
exploit these pests as prey and hosts. Thus, the
the risk assessment should focus on nontarget coleopteran species rather than species
potential for these indirect ecological effects
belonging to other taxonomic groups.
on biological control organisms should not be
regarded as a unique ecological risk associated
Example 3: novel Bt maize event without toxin expression in the pollen. Honeybees are
with the IRGM crop8,18,22. Large reductions,
exposed only to insecticidal proteins expressed by GM maize varieties when these are
however,
should be expected if the pest manpresent in the pollen. If the proteins are not expressed in the pollen, there is no scientific
agement strategy is effective. Because IRGM
justification for conducting feeding studies with bees or other pollen-feeding arthropods.
crops are often grown in vicinity with non-GM

using alternative designs may be conducted at the initial stage of the
risk assessment process when lower tier tests are not possible. Lower tier
tests are, however, extremely valuable to the ERA process because they are
highly controlled, and may provide data that are broadly applicable within
various risk assessments. It should be noted that field observations on Bt
crops have failed to find any adverse NTA impacts that could not have been
predicted from laboratory or small-scale field studies22,26.
Movement between tiers takes place either because the available information is insufficient to accept the risk hypothesis of ‘no effect’ or because
this hypothesis has been rejected. If sufficient data and experience from
toxicological testing and exposure analyses are available to characterize
the potential risk as being acceptable, then there is no need to undertake
additional testing (Fig. 1). The iterative and flexible tiered testing scheme
described herein is designed to provide the information to support a regulatory decision as efficiently and rigorously as possible. In cases where the
risk hypothesis is rejected at the highest tier (Fig. 1, Tiern+x), an adverse
impact on NTAs can occur. As a consequence, the GM variety may either
not be authorized or the regulatory agency may require monitoring or risk
mitigation. Alternatively, a new problem formulation may be required in
cases where a potentially adverse outcome is found.
A key principle of the tiered process is that particular studies are conducted only when they serve to reduce uncertainty in the risk assessment.
Where no hazard or risk is detected, effective tiered processes prevent
costly and unnecessary testing (see Supplementary Note; the lacewing
case). Consequently, the assessment of different risk hypotheses will follow
different evaluation paths (Box 1 and Fig. 2). The process is designed to
optimize the expenditure of resources by identifying and defining sources
of potential risk, thereby minimizing the collection of data that are irrelevant to the risk assessment.

206

VOLUME 26 NUMBER 2 FEBRUARY 2008 NATURE BIOTECHNOLOGY

PERSPECTIVE

© 2008 Nature Publishing Group http://www.nature.com/naturebiotechnology

crops to prevent resistance build-up by the target pest(s)37, specialist
antagonists can persist in these ‘refuges’, in other crops and in non-crop
habitats and retain the potential for recolonization of the IRGM crop
area. On the basis of these considerations, regulatory testing of the specialist predators and parasitoids of target pests may not be necessary.
Study design
Once the surrogate species are selected, they should be evaluated in
scientifically designed and validated studies to test the risk hypotheses.
Historically, protocols developed to assess the impact of pesticides on
NTAs38,39 formed the basis for the tests used to evaluate IRGM plants.
These protocols were modified to account for the oral exposure pathway and the potential for extended exposure time to plant-expressed
insecticidal proteins40. New protocols are being developed to address the
specific research or regulatory needs associated with IRGM risk assessment. The new or modified tests often span a significant portion of the
test insect lifespan, which is appropriate for the period of exposure to the
toxin in the field, and may include a number of measurement endpoints
in addition to mortality (see Supplementary Note for examples using
these new protocols).

The species tested should provide the most rigorous tests of the risk
hypotheses for a particular IRGM plant in a specific agricultural and
environmental setting.
And third, more standardized, validated test protocols for surrogate
test species may need to be developed. These are needed to ensure data
comparability and facilitate international regulatory acceptance.
We believe that the tiered NTA testing approach presented above
minimizes the likelihood of false negatives, which could result in the
release of IRGM plants with undesirable effects on NTAs and, at the
same time, should reverse the trend of increased delays for introducing products that may be environmentally more benign than existing
methods of pest control41.
Note: Supplementary information is available on the Nature Biotechnology website.
DISCLAIMER
In addition to scientists that work within the public sector, the IOBC/WPRS
working group includes scientists that work within regulatory agencies, the
commercial biotech industry and commercial contract laboratories. Although
these organizations have an interest in the final outcome of the working group
program, members of the working group participate as individuals, not as
representatives of these organizations. The publications of the working group
reflect a consensus that has developed as a result of its open meetings and
discussions and the opinions expressed by individuals or in working group
publications may not necessarily, therefore, represent the policies of their
organizations. Any mention of a proprietary product in meetings or publications
does not constitute an endorsement or a recommendation by the working group.
There is no commercial sponsorship or endorsement for the working group or
its members, beyond the support provided to individual participants by their
organizations to attend meetings.

Conclusions
The tiered NTA testing approach presented here provides the scientific
rationale for the ERA of IRGM crops to assist regulatory decision making. The framework provides a well-defined and predictable pathway for
requesting, acquiring, organizing and evaluating data. It is the consensus
of a diverse group of stakeholders and therefore provides a basis for
improving harmonization of international risk assessment guidelines.
Harmonized procedures in ERA help to facilitate risk assessment data
acceptability and provide greater scope for comparison of ecological
effects data internationally.
The approach presented here ensures rigorous testing of clearly stated
and relevant risk hypotheses that are linked to defined assessment endpoints while optimizing data requirements. The risk hypotheses are
developed from current knowledge about the biology of the crop, the
introduced trait, the receiving environment and the interactions of all
three. It therefore makes maximum use of the existing data and aims to
minimize collection of data that are irrelevant to the risk assessment. The
process is intended to be efficient and rigorous, focusing the resources
to address potential risks or uncertainties and eliminating from further
consideration the risks that are negligible. Potential hazards are evaluated with representative surrogate/indicator species that are selected
case by case for their suitability and amenability to test relevant risk
hypotheses.
The general approach we outline here has evolved based upon current events and insecticidal proteins and is flexible and adaptable to
new IRGM products. Several aspects of the approach may, however,
have to be further developed to take account of new traits and potential risks.
First, threshold values need to be defined that trigger the advance
to higher tiers as has been done for environmental risk assessments of
conventional pesticides32,33. If these trigger values are not exceeded, the
testing stops and the regulatory decision follows. The specific triggers
applied in a given case of an ERA for IRGM plants are informed by
expert opinion and require deliberation among risk assessors and risk
managers, who consider the problem being evaluated and the effects
regarded as ‘acceptable’. We recognize, however, that defining the trigger
values is not solely a scientific question but also depends on whether
policy-makers are concerned about under- or overestimating risks.
Second, a list of surrogate species needs to be compiled that can serve
as a basis for selecting the most appropriate species for laboratory testing.
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